Clinical Trial Update: 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) [Phase 3]

View source ↗

Summary

Phase 3 extension trial of asenapine with olanzapine in schizophrenia patients who completed the protocol; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Asenapine (asenapine)
• olanzapine (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2010-02-23